background image

Clinical Trials In New York State

Discover hundreds of clinical trials in New York State.
Search clinical trials in New York State by city, condition or phase.

e.g. Respiratory Diseases
New York State•Healthy volunteers: No

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Dothan, Dothan, Dothan, Dothanshow 271 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting
PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Alexander City, Fairhope, Huntsville, Phoenixshow 163 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Recruiting
PHASE3

Sponsor:

Bellus Health Inc. - a GSK company

Location:

Jasper, Litchfield Park, Scottsdale, Little Rockshow 58 more

Code:

NCT05599191

Conditions

Refractory Chronic Cough

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BLU-5937

Placebo

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Recruiting
PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Birmingham, Montgomery, Glendale, Mesashow 191 more

Code:

NCT05021835

Conditions

Cardiovascular Risk

Chronic Kidney Disease

Inflammation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab B

Ziltivekimab C

Placebo (Ziltivekimab B)

Placebo (Ziltivekimab C)

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

New York

Code:

NCT05561842

Conditions

Breast Cancer

Breast Cancer Female

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

mHealth US-breast biopsy

A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Chandler, Gilbert, Gilbert, Gilbertshow 159 more

Code:

NCT05654623

Conditions

Advanced Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ARV-471

Fulvestrant

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Phoenix, Hanford, West Hollywood, Aurorashow 49 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

Recruiting
PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Alexander City, Birmingham, Birmingham, Daphneshow 107 more

Code:

NCT06008756

Conditions

Arteriosclerosis

Hypercholesterolaemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enlicitide Decanoate

Placebo

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Boca Raton, New York, Cincinnati, Salt Lake City

Code:

NCT05682378

Conditions

Heterozygous or Homozygous Familial Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Inclisiran

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Recruiting
PHASE3

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

Gilbert, New Haven, Newark, Boca Ratonshow 37 more

Code:

NCT03574571

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Docetaxel 75 mg/m2

Docetaxel 60 mg/m2

Radium-223

Popular cities in New York State